{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:35:03Z","timestamp":1782387303368,"version":"3.54.5"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-025-01928-7","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T05:02:11Z","timestamp":1751605331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Epigenetic regulation of TNNT1 in gastrointestinal cancers prognostic implications and clinical significance"],"prefix":"10.1186","volume":"17","author":[{"given":"Jin","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3663-1096","authenticated-orcid":false,"given":"Xu-Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"1928_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1928_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1928_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S2468-1253(21)00426-X","volume":"7","author":"SG Patel","year":"2022","unstructured":"Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet, Gastroenterol Hepatol. 2022;7:262\u201374.","journal-title":"Lancet, Gastroenterol Hepatol"},{"key":"1928_CR4","doi-asserted-by":"publisher","first-page":"107327482094597","DOI":"10.1177\/1073274820945975","volume":"27","author":"Y-S Ma","year":"2020","unstructured":"Ma Y-S, Liu J-B, Wu T-M, Fu D. New therapeutic options for advanced hepatocellular Carcinoma. Cancer Control. 2020;27:1073274820945975.","journal-title":"Cancer Control"},{"key":"1928_CR5","doi-asserted-by":"publisher","first-page":"1142498","DOI":"10.3389\/fmolb.2023.1142498","volume":"10","author":"S Li","year":"2023","unstructured":"Li S, Li Q, Ren Y, Yi J, Guo J, Kong X. HSV: The scout and assault for digestive system tumors. Front Mol Biosci. 2023;10:1142498.","journal-title":"Front Mol Biosci"},{"key":"1928_CR6","doi-asserted-by":"publisher","first-page":"1129062","DOI":"10.1155\/2022\/1129062","volume":"2022","author":"S Huang","year":"2022","unstructured":"Huang S, Wang X, Luo K, Zhang X, Liu Z, Li R. Combined evaluation of mRNA and protein expression, promoter methylation, and immune infiltration of UBE2I in pan-digestive system tumors. Oxid Med Cell Longev. 2022;2022:1129062.","journal-title":"Oxid Med Cell Longev"},{"key":"1928_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nrclinonc.2016.15","volume":"13","author":"F Lordick","year":"2016","unstructured":"Lordick F, Janjigian YY. Clinical impact of tumour biology in the management of gastroesophageal cancer. Nat Rev Clin Oncol. 2016;13:348\u201360.","journal-title":"Nat Rev Clin Oncol"},{"key":"1928_CR8","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/s43018-021-00250-4","volume":"2","author":"F Chen","year":"2021","unstructured":"Chen F, Wendl MC, Wyczalkowski MA, Bailey MH, Li Y, Ding L. Moving pan-cancer studies from basic research toward the clinic. Nat Cancer. 2021;2:879\u201390.","journal-title":"Nat Cancer"},{"key":"1928_CR9","doi-asserted-by":"publisher","first-page":"962743","DOI":"10.3389\/fmolb.2022.962743","volume":"9","author":"V Raufaste-Cazavieille","year":"2022","unstructured":"Raufaste-Cazavieille V, Santiago R, Droit A. Multi-omics analysis: Paving the path toward achieving precision medicine in cancer treatment and immuno-oncology. Front Mol Biosci. 2022;9:962743.","journal-title":"Front Mol Biosci"},{"key":"1928_CR10","doi-asserted-by":"publisher","first-page":"1010879","DOI":"10.3389\/fphar.2022.1010879","volume":"13","author":"X-S Liu","year":"2022","unstructured":"Liu X-S, Liu C, Zeng J, Zeng D-B, Chen Y-J, Tan F, et al. Nucleophosmin 1 is a prognostic marker of gastrointestinal cancer and is associated with m6A and cuproptosis. Front Pharmacol. 2022;13:1010879.","journal-title":"Front Pharmacol"},{"key":"1928_CR11","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1038\/s41598-024-54670-0","volume":"14","author":"X-S Liu","year":"2024","unstructured":"Liu X-S, Chen Y-X, Wan H-B, Wang Y-L, Wang Y-Y, Gao Y, et al. TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association. Sci Rep. 2024;14:4042.","journal-title":"Sci Rep"},{"key":"1928_CR12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1515\/oncologie-2023-0024","volume":"25","author":"M Luo","year":"2023","unstructured":"Luo M, Tang J, Zhu Y, Wu L, Fu H, Zhang F, et al. MiRNA-219a-1-3p inhibits the malignant progression of gastric cancer and is regulated by DNA methylation. Oncologie. 2023;25:495\u2013506.","journal-title":"Oncologie"},{"key":"1928_CR13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.32604\/biocell.2024.048076","volume":"48","author":"X Shi","year":"2024","unstructured":"Shi X, Wang Y, Li C, Fu W, Zhang X, Gong A. Knockdown of RCN1 contributes to the apoptosis of colorectal cancer via regulating IP3R1. Biocell. 2024;48:835\u201345.","journal-title":"Biocell"},{"key":"1928_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/med4.72","volume":"2","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Cao H, Yang F, Wang X, Xu Z, Cheng M, et al. Comprehensive analyses of nuclear mitochondria-related genes in the molecular features, immune infiltration, and drug sensitivity of clear cell renal cell carcinoma. Medicine Advances. 2024;2:238\u201353.","journal-title":"Medicine Advances"},{"key":"1928_CR15","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1186\/s12885-024-12261-2","volume":"24","author":"L Dreikhausen","year":"2024","unstructured":"Dreikhausen L, Klupsch A, Wiest I, Xiao Q, Schulte N, Betge J, et al. Clinical impact of panel gene sequencing on therapy of advanced cancers of the digestive system: a retrospective, single center study. BMC Cancer. 2024;24:526.","journal-title":"BMC Cancer"},{"key":"1928_CR16","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/ajg.2008.145","volume":"104","author":"FM Selaru","year":"2009","unstructured":"Selaru FM, David S, Meltzer SJ, Hamilton JP. Epigenetic events in gastrointestinal cancer. Am J Gastroenterol. 2009;104:1910\u20132.","journal-title":"Am J Gastroenterol"},{"key":"1928_CR17","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1111\/1759-7714.15400","volume":"15","author":"X Ge","year":"2024","unstructured":"Ge X, Du G, Zhou Q, Yan B, Yue G. TNNT1 accelerates migration, invasion and EMT progression in lung cancer cells. Thorac Cancer. 2024;15:1749\u201356.","journal-title":"Thorac Cancer"},{"key":"1928_CR18","doi-asserted-by":"publisher","first-page":"147331","DOI":"10.1016\/j.gene.2023.147331","volume":"865","author":"S-C Huang","year":"2023","unstructured":"Huang S-C, Huang C-C, Ko C-Y, Huang C-Y, Liu C-H, Lee Y-K, et al. Slow skeletal muscle troponin T acts as a potential prognostic biomarker and therapeutic target for hepatocellular carcinoma. Gene. 2023;865:147331.","journal-title":"Gene"},{"key":"1928_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s40618-023-02132-1","volume":"47","author":"C Jiang","year":"2024","unstructured":"Jiang C, Xu F, Yi D, Jiang B, Wang R, Wu L, et al. Testosterone promotes the migration, invasion and EMT process of papillary thyroid carcinoma by up-regulating Tnnt1. J Endocrinol Invest. 2024;47:149\u201366.","journal-title":"J Endocrinol Invest"},{"key":"1928_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/09168451.2019.1664891","volume":"84","author":"Y-H Hao","year":"2020","unstructured":"Hao Y-H, Yu S-Y, Tu R-S, Cai Y-Q. TNNT1, a prognostic indicator in colon adenocarcinoma, regulates cell behaviors and mediates EMT process. Biosci Biotechnol Biochem. 2020;84:111\u20137.","journal-title":"Biosci Biotechnol Biochem"},{"key":"1928_CR21","doi-asserted-by":"publisher","first-page":"e3152","DOI":"10.1002\/jgm.3152","volume":"22","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang J, Wang D, Kang T, Du J, Yan Z, et al. TNNT1, negatively regulated by miR-873, promotes the progression of colorectal cancer. J Gene Med. 2020;22:e3152.","journal-title":"J Gene Med"},{"key":"1928_CR22","first-page":"e3405","volume":"21","author":"Y Li","year":"2023","unstructured":"Li Y, Qu J, Sun Y, Chang C. Troponin T1 promotes the proliferation of ovarian cancer by regulating cell cycle and apoptosis. Iran J Biotechnol. 2023;21:e3405.","journal-title":"Iran J Biotechnol"},{"key":"1928_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.lfs.2018.07.034","volume":"208","author":"Y Shi","year":"2018","unstructured":"Shi Y, Zhao Y, Zhang Y, AiErken N, Shao N, Ye R, et al. TNNT1 facilitates proliferation of breast cancer cells by promoting G1\/S phase transition. Life Sci. 2018;208:161\u20136.","journal-title":"Life Sci"},{"key":"1928_CR24","doi-asserted-by":"publisher","first-page":"e18410","DOI":"10.1111\/jcmm.18410","volume":"28","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Hao L, Wang F, Yu Q, Wu S, Han C. Troponin T1 in tumorigenesis and immune modulation: Insights into multiple cancers and kidney renal clear cell carcinoma. J Cell Mol Med. 2024;28:e18410.","journal-title":"J Cell Mol Med"},{"key":"1928_CR25","doi-asserted-by":"publisher","first-page":"14109","DOI":"10.18632\/aging.205293","volume":"15","author":"L Zang","year":"2023","unstructured":"Zang L, Zhang B, Zhou Y, Zhang F, Tian X, Tian Z, et al. Machine learning algorithm integrates bulk and single-cell transcriptome sequencing to reveal immune-related personalized therapy prediction features for pancreatic cancer. Aging-us. 2023;15:14109\u201340.","journal-title":"Aging-us"},{"key":"1928_CR26","doi-asserted-by":"publisher","first-page":"e39678","DOI":"10.1097\/MD.0000000000039678","volume":"103","author":"AH Al Sharie","year":"2024","unstructured":"Al Sharie AH, Al Masoud EB, Jadallah RK, Alzghoul SM, Darweesh RF, Al-Bataineh R, et al. Transcriptome analysis revealed a novel nine-gene prognostic risk score of clear cell renal cell carcinoma. Medicine (Baltimore). 2024;103:e39678.","journal-title":"Medicine (Baltimore)"},{"key":"1928_CR27","doi-asserted-by":"publisher","first-page":"9881","DOI":"10.1038\/s41598-024-60581-x","volume":"14","author":"X-S Liu","year":"2024","unstructured":"Liu X-S, Chen Y-L, Chen Y-X, Wu R-M, Tan F, Wang Y-L, et al. Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers. Sci Rep. 2024;14:9881.","journal-title":"Sci Rep"},{"key":"1928_CR28","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1111\/cas.14210","volume":"110","author":"M Korenjak","year":"2019","unstructured":"Korenjak M, Zavadil J. Experimental identification of cancer driver alterations in the era of pan-cancer genomics. Cancer Sci. 2019;110:3622\u20139.","journal-title":"Cancer Sci"},{"key":"1928_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5114\/wo.2014.47136","volume":"1A","author":"K Tomczak","year":"2015","unstructured":"Tomczak K, Czerwi\u0144ska P, Wiznerowicz M. Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Wsp\u00f3\u0142czesna Onkol. 2015;1A:68\u201377.","journal-title":"Wsp\u00f3\u0142czesna Onkol"},{"key":"1928_CR30","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173:400-416.e11.","journal-title":"Cell"},{"key":"1928_CR31","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","volume":"23","author":"S Davis","year":"2007","unstructured":"Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics. 2007;23:1846\u20137.","journal-title":"Bioinformatics"},{"key":"1928_CR32","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2012","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets\u2014update. Nucleic Acids Res. 2012;41:D991\u20135.","journal-title":"Nucleic Acids Res"},{"key":"1928_CR33","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"1928_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1471-2105-15-293","volume":"15","author":"P Bardou","year":"2014","unstructured":"Bardou P, Mariette J, Escudi\u00e9 F, Djemiel C, Klopp C. jvenn: an interactive venn diagram viewer. BMC Bioinf. 2014;15:293.","journal-title":"BMC Bioinf"},{"key":"1928_CR35","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucl Acids Res. 2015;43:e47.","journal-title":"Nucl Acids Res"},{"key":"1928_CR36","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS: J Integr Biol. 2012;16:284\u20137.","journal-title":"OMICS: J Integr Biol"},{"key":"1928_CR37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK, et al. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19:649\u201358.","journal-title":"Neoplasia"},{"key":"1928_CR38","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signaling. 2013;6:pl1\u2013pl1.","journal-title":"Sci Signaling"},{"key":"1928_CR39","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"1928_CR40","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12859-023-05615-3","volume":"24","author":"C Liao","year":"2023","unstructured":"Liao C, Wang X. TCGAplot: an R package for integrative pan-cancer analysis and visualization of TCGA multi-omics data. BMC Bioinform. 2023;24:483.","journal-title":"BMC Bioinform"},{"key":"1928_CR41","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"key":"1928_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinf. 2013;14:7.","journal-title":"BMC Bioinf"},{"key":"1928_CR43","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, et al. TIMER: A web server for comprehensive analysis of tumor-infiltrating immuneCells. Cancer Res. 2017;77:e108\u201310.","journal-title":"Cancer Res"},{"key":"1928_CR44","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s40001-025-02541-3","volume":"30","author":"X-S Liu","year":"2025","unstructured":"Liu X-S, Xu Y, Dai L-S, Li A, Liu J, Zhang Y, et al. The potential of MCM8 as a biomarker in esophageal carcinoma: a comprehensive analysis integrating m6a methylation and angiogenesis. Eur J Med Res. 2025;30:373.","journal-title":"Eur J Med Res"},{"key":"1928_CR45","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s40001-025-02407-8","volume":"30","author":"X-S Liu","year":"2025","unstructured":"Liu X-S, Xie J, Wu R-M, Xiao G-C, Zhang Y, Pei Z-J. Expression patterns of MCM8 in lung adenocarcinoma and its correlation with key biological processes. Eur J Med Res. 2025;30:149.","journal-title":"Eur J Med Res"},{"key":"1928_CR46","doi-asserted-by":"crossref","unstructured":"Zeng H, Zheng R, Sun K, Zhou M, Wang S, Li L, et al. Cancer survival statistics in China 2019\u20132021: a multicenter, population-based study. Journal of the National Cancer Center. 2024; S2667005424000498.","DOI":"10.1016\/j.jncc.2024.06.005"},{"key":"1928_CR47","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.32604\/biocell.2024.052451","volume":"48","author":"H Sun","year":"2024","unstructured":"Sun H, Wang H, Hao Y, Li X, Ling J, Wang H, et al. MAD2L2 overexpression attenuates the effects of TNF-\u03b1-induced migration and invasion capabilities in colorectal cancer cells. Biocell. 2024;48:1311\u201322.","journal-title":"Biocell"},{"key":"1928_CR48","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1515\/oncologie-2023-0562","volume":"26","author":"J Chen","year":"2024","unstructured":"Chen J, Yang T, Xiao T, Wang Z, He F, Bao T, et al. Overview and new insights of lysine-specific histone demethylase 1 in colorectal cancer: promoting epithelial-mesenchymal transition and stemness features of cancer stem cells. Oncologie. 2024;26:369\u201377.","journal-title":"Oncologie"},{"key":"1928_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cpan.2024.12.001","volume":"21","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zhao Y, Zhang L. Emerging trends and hot topics in the application of multi-omics in drug discovery: a bibliometric and visualized study. Curr Pharm Anal. 2024;21:20\u201332.","journal-title":"Curr Pharm Anal"},{"key":"1928_CR50","doi-asserted-by":"publisher","first-page":"e77309","DOI":"10.1371\/journal.pone.0077309","volume":"8","author":"I Ibragimova","year":"2013","unstructured":"Ibragimova I, Slifker MJ, Maradeo ME, Banumathy G, Dulaimi E, Uzzo RG, et al. Genome-wide promoter methylome of small renal masses. PLoS ONE. 2013;8:e77309.","journal-title":"PLoS ONE"},{"key":"1928_CR51","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1186\/s12885-021-08653-3","volume":"21","author":"J Wang","year":"2021","unstructured":"Wang J, Xu P, Hao Y, Yu T, Liu L, Song Y, et al. Interaction between DNMT3B and MYH11 via hypermethylation regulates gastric cancer progression. BMC Cancer. 2021;21:914.","journal-title":"BMC Cancer"},{"key":"1928_CR52","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/cancers13030545","volume":"13","author":"A Mehdi","year":"2021","unstructured":"Mehdi A, Rabbani SA. Role of methylation in pro- and anti-cancer immunity. Cancers. 2021;13:545.","journal-title":"Cancers"},{"key":"1928_CR53","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00535-023-02058-8","volume":"59","author":"T Sakakida","year":"2024","unstructured":"Sakakida T, Ishikawa T, Doi T, Morita R, Kataoka S, Miyake H, et al. Genomic profile and clinical features of MSI-H and TMB-high pancreatic cancers: real-world data from C-CAT database. J Gastroenterol. 2024;59:145\u201356.","journal-title":"J Gastroenterol"},{"key":"1928_CR54","doi-asserted-by":"publisher","first-page":"100336","DOI":"10.1016\/j.esmoop.2021.100336","volume":"7","author":"M Palmeri","year":"2022","unstructured":"Palmeri M, Mehnert J, Silk AW, Jabbour SK, Ganesan S, Popli P, et al. Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers. ESMO Open. 2022;7:100336.","journal-title":"ESMO Open"},{"key":"1928_CR55","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.3390\/ijms23095097","volume":"23","author":"M-T Sung","year":"2022","unstructured":"Sung M-T, Wang Y-H, Li C-F. Open the technical black box of tumor mutational burden (TMB): factors affecting harmonization and standardization of panel-based TMB. Int J Mol Sci. 2022;23:5097.","journal-title":"Int J Mol Sci"},{"key":"1928_CR56","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41698-023-00442-4","volume":"7","author":"D Wang","year":"2023","unstructured":"Wang D, Elenbaas B, Murugesan K, Shah K, Montesion M, Gounaris I, et al. Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays. NPJ Precis Oncol. 2023;7:103.","journal-title":"NPJ Precis Oncol"},{"key":"1928_CR57","doi-asserted-by":"publisher","first-page":"e003773","DOI":"10.1136\/jitc-2021-003773","volume":"9","author":"C Hu","year":"2021","unstructured":"Hu C, Zhao L, Liu W, Fan S, Liu J, Liu Y, et al. Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers. J Immunother Cancer. 2021;9:e003773.","journal-title":"J Immunother Cancer"},{"key":"1928_CR58","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1158\/0008-5472.CAN-23-2123","volume":"84","author":"X Liu","year":"2024","unstructured":"Liu X, Wang X, Yang Q, Luo L, Liu Z, Ren X, et al. Th17 cells secrete TWEAK to trigger epithelial-mesenchymal transition and promote colorectal cancer liver metastasis. Cancer Res. 2024;84:1352\u201371.","journal-title":"Cancer Res"},{"key":"1928_CR59","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41423-018-0004-4","volume":"15","author":"HM Knochelmann","year":"2018","unstructured":"Knochelmann HM, Dwyer CJ, Bailey SR, Amaya SM, Elston DM, Mazza-McCrann JM, et al. When worlds collide: Th17 and treg cells in cancer and autoimmunity. Cell Mol Immunol. 2018;15:458\u201369.","journal-title":"Cell Mol Immunol"},{"key":"1928_CR60","doi-asserted-by":"publisher","first-page":"e70033","DOI":"10.1002\/imt2.70033","volume":"4","author":"J Hu","year":"2024","unstructured":"Hu J, Yan L, Liu J, Chen M, Liu P, Deng D, et al. Efficacy and biomarker analysis of neoadjuvant disitamab vedotin (RC48-ADC) combined immunotherapy in patients with muscle-invasive bladder cancer: a multi-center real-world study. iMeta. 2024;4:e70033.","journal-title":"iMeta"},{"key":"1928_CR61","doi-asserted-by":"publisher","first-page":"100785","DOI":"10.1016\/j.xcrm.2022.100785","volume":"3","author":"J Hu","year":"2022","unstructured":"Hu J, Chen J, Ou Z, Chen H, Liu Z, Chen M, et al. Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: a multi-center real-world retrospective study. Cell Rep Med. 2022;3:100785.","journal-title":"Cell Rep Med"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01928-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-025-01928-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01928-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T06:02:43Z","timestamp":1751608963000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-025-01928-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1928"],"URL":"https:\/\/doi.org\/10.1186\/s13148-025-01928-7","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"2 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by Ethics Committee of Taihe Hospital Affiliated of Hubei University of Medicine (No. 2025KS35), and was in accordance with the Declaration of Helsinki. Written informed consent for participation was not required for this study in accordance with the Ethics Committee of Taihe Hospital Affiliated with Hubei University of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}